Raffles Medical Likely a Defensive Option Amid Volatility -- Market Talk

Dow Jones

04-08

0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com)

(END) Dow Jones Newswires

April 07, 2025 23:39 ET (03:39 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2525870887"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2525870887\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2525870887?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-04-08 11:39","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2525870887","market":"sg","top_or_hot":-1,"title":"Raffles Medical Likely a Defensive Option Amid Volatility -- Market Talk","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 07, 2025 23:39 ET (03:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Raffles Medical Likely a Defensive Option Amid Volatility -- Market Talk</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRaffles Medical Likely a Defensive Option Amid Volatility -- Market Talk\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2025-04-08 11:39</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\n     0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com) \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  April 07, 2025 23:39 ET (03:39 GMT)\n</p>\n<p>\n  Copyright (c) 2025 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BSL.SI","symbol_name":"萊佛士醫療","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2525870887","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2525870887","pubTimestamp":1744083540,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BSL.SI":"莱佛士医疗","BK6511":"医疗保健服务概念","BK6092":"保健护理机构"},"translate_title":"莱佛士医疗可能是波动中的防御性选择——市场讨论","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BSL.SI":1},"content_text":"0339 GMT - Raffles Medical Group is a likely defensive option in a volatile market, RHB Research's Shekhar Jaiswal says in a research report. Patient load for its healthcare business has normalized and this segment is now devoid of pandemic-related revenue, implying annual healthcare revenue may now exceed prepandemic levels, the analyst says. The hospital business should also enjoy higher revenue as its China-based hospitals, which had been affected by pandemic restrictions,start to scale up their operations, the analyst adds. RHB upgrades the stock to buy from neutral and raises the target price to S$1.08 from S$0.95 to factor in the defensive nature of Raffles Medical's earnings in the current uncertain macroeconomic environment. Shares are 2.7% higher at S$0.945. (ronnie.harui@wsj.com) \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  April 07, 2025 23:39 ET (03:39 GMT)\n\n\n  Copyright (c) 2025 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}